International Journal of Gynecological Pathology · 2006 · 72 citations · 18 references
MedicineCell BiologyOncologyCell SignalingMetastasisMolecular OncologyCancer Cell SignalingCell-matrix AdhesionMalignant NeoplasmsOvarian CancerTumor-stroma InteractionsCd44 ExpressionCell InvasionCurative TherapyOvarian Cancer BiomarkersOvarian Cancer MetastasisOvarian Cancer PathogenesisTumor Invasion Assessment
The majority of patients diagnosed with ovarian carcinoma are classified as being in advanced stage of disease. In a situation of cancer spread throughout the abdominal cavity, a successful curative treatment is difficult to achieve. Therefore, preventing binding of tumor cells to the mesothelium is crucial for patients' outcome. One important mechanism is the interaction between hyaluronic acid and the CD44 receptor with its submembrane linking complex. This consists of ezrin, radixin, and moesin and connects the CD44 receptor with the cytoskeleton. To assess the role of ezrin and moesinfor ovarian carcinoma progression, we analyzed ovarian carcinoma samples from 105 patients for expression of ezrin and moesin by immunohistochemistry and correlated these data with several clinicopathological parameters. To elucidate the functional importance of ezrin and moesin, their expression was inhibited in SKOV-3 cells by RNA interference. Ezrin and moesin were strongly expressed in 49 and 48% of ovarian carcinoma samples, respectively, and their presence correlated with reduced overall survival in univariate analysis (ezrin, p=0.0189; moesin, p=0.0351). In multivariate analysis (including FIGO stage, residual tumor, histological type, and Silverberg grading), ezrin still remained significant as an independent risk factor (relative risk, 2.39; p=0.012). In SKOV-3 cells, siRNA against ezrin but not moesin inhibited in vitro invasion. These data imply that ezrin is necessary for tumor cell invasion, and the better prognosis of ovarian carcinomas lacking ezrin is probably related to their impaired invasion.
18
Analysis of gene function in somatic mammalian cells using small interfering RNAs
Sayda M. Elbashir · Methods · 2002 · 1.1K citations · Full text
Alexis Gautreau, Patrick Poullet, Daniel Louvard et al. · Proceedings of the National Academy of Sciences · 1999 · 329 citations
Deborah Mackay, Fred Esch, Heinz Furthmayr et al. · The Journal of Cell Biology · 1997 · 301 citations · Full text
Karen A. Bell, Ann E. Smith Sehdev, Robert J. Kurman · The American Journal of Surgical Pathology · 2001 · 160 citations
Medicine, Gynecology, Oncology +16